E.А. ABDULAEVA

Kazan State Medical Academy ― Branch Campus of the RMACPE MOH Russia, 36 Butlerov Str., Kazan, Russian Federation, 420012

Abdulaeva E.A. ― Cand. Med. Sc., Associate Professor of the Department of Ophthalmology, tel. +7-987-296-93-44, e-mail: abd@inbox.ru

 The article presents a review of literature devoted to the problem of retinal angiomatous proliferation. The clinical classification is described, diagnostic features are determined, available methods of treatment, research results and prospects are presented.

Key words: retinal angiomatous proliferation, choroidal neovascularization, age-related macular degeneration, indocyanine green angiography, photodynamic therapy.

REFERENCES

1. Yannuzzi L.A., Freund K.B., Takahashi B.S. Review of retinal angiomatous proliferation or type 3 neovascularization. Retina, 2008, no. 28 (3), pp. 375-384.
2. Freund K.B., Ho I.V., Barbazetto I.A., Koizumi H., Laud K., Ferrara D., et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina, 2008, no. 28 (2), pp. 201-211.
3. Yannuzzi L.A., Negrao S., Iida T., Carvalho C., Rodriguez-Coleman H., Slakter J., et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina, 2001, no. 21 (5), pp. 416-434.
4. Viola F., Massacesi A., Orzalesi N., Ratiglia R., Staurenghi G. Retinal angiomatous proliferation: natural history and progression of visual loss. Retina, 2009, no. 29 (6), pp. 732-739.
5. Scott A.W., Bressler S.B. Retinal angiomatous proliferation or retinal anastomosis to the lesion. Eye, 2010, no. 24, pp. 491-496.
6. Bressler N.M. Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. Arch. Ophthalmology, 2005, no. 123 (12), pp. 1741-1743.
7. Gross N.E., Aizman A., Brucker A., et al. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina, 2005, no. 25, pp. 713-718.
8. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study report number 3. Ophthalmology, 2000, no. 107, pp. 2224-2232.
9. Slakter J.S., Yannuzzi L.A., Schneider U., et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology, 2000, no. 107, pp. 742-754
10. Yannuzzi L.A., Bardal A., Freund K.B., et al. Idiopathic macular telangiectasia. Arch. Ophthalmology, 2006, no. 124, pp. 450-460
11. Stepanova E.A., Berezin A.V., Bobykin E.V. The first experience of the use of angiography with indocyanine green in the diagnosis of latent forms of choroidal neovascularization. Otrazhenie, 2015, no. 1, pp. 92-93 (in Russ.).
12. Gorelova E.V., Pedanova E.K., Kachalina G.F. Diagnostic criteria for retinal angiomatous proliferation as a special form of age-related macular degeneration. Sovremennye tekhnologii v oftal’mologii, 2015, no. 3, pp. 51-53 (in Russ.).
13. Brancato R., Introini U., Pierro L. et al. Optical coherence tomography (OCT) angiomatous proliferation (RAP) in retina. Eur. J. Ophthalmology, 2002, no. 12, pp. 467-472.
14. Truong S.N., Alam S., Zawadzki R.J., et al. High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation. Retina, 2007, no. 27, pp. 915-925.
15. Shaimov T.B., Kuznetsov A.A., Shaimov R.B. Clinical and instrumental criteria for the diagnosis of retinal angiomatous proliferation as a variant of the course of age-related macular degeneration. Meditsinskiy vestnik Bashkortostana, 2014, no. 9 (2), pp. 151-153 (in Russ.).
16. Rouvas A.A., Papakostas T.D., Ntouraki A. Angiographic and OCT features of retinal angiomatous proliferation. Eye, 2010, no. 24 (11), pp. 1633-1642.
17. Bottoni F., Massacesi A., Cigada M., Viola F., Musicco I., Staurenghi G. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.. Arch Ophthalmology, 2005, no. 123 (12), pp. 1644-1650.
18. Rouvas A.A., Papakostas T.D., Vavvas D., et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina, 2009, no. 29, pp. 536-544.
19. Park Y.G., Roh Y.J. One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages. BMC Ophthalmology, 2015, no. 15, p. 182.
20. Gupta B., Jyothi S., Sivaprasad S. Current treatment options for retinal angiomatous proliferans. Br. J. Ophthalmology, 2010, no. 94, pp. 672-677.
21. Hartnett M.E., Weiter J.J., Staurenghi G., et al. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology, 1996, no. 103, pp. 2042-2053.
22. Bearelly S., Espinosa-Heidmann D.G., Cousins S.W. The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation. Br. J. Ophthalmology, 2008, no. 92, pp. 191-196.
23. Kramann C.A., Schopfer K., Lorenz K., Zwiener I., Stoffelns B.M., Pfeiffer N. Intravitreal ranibizumab treatment of retinal angiomatous proliferation. Acta Ophthalmology, 2012, no. 90 (5), P. 487-491.
24. Atmani K., Voigt M., Le Tien V., Querques G., Coscas G., Soubrane G., et al. Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration. Eye, 2010, no. 24 (7), pp. 1193-1198.
25. Koizumi H., Iida T., Saito M., Nagayama D., Maruko I. Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography. Graefes Arch. Clin. Exp. Ophthalmology, 2008, no. 246, pp. 515-520.
26. Monson D.M., Smith J.R., Klein M.L., Wilson D.J. Clinicopathologic correlation of retinal angiomatous proliferation. Arch. Ophthalmology, 2008, no. 126, pp. 1664-1668.
27. Ghazi N.G., Knape R.M., Kirk T.Q., Tiedeman J.S., Conway B.P. Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation. Retina, 2008, no. 28, pp. 689-695.
28. Meyerle C.B., Freund B., Iturralde D., Spaide R.F., Sorenson J.A., Slakter J.S. et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina, 2007, no. 27, pp. 451-457.
29. Gharbiya M., Allievi F., Recupero V., Martini D., Mazzeo L., Gabrieli C.B. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina, 2009, no. 29, pp. 740-749.
30. Lai T.Y., Chan W.M., Liu D.T., Lam D.S. Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmology, 2007, no. 245, pp. 1877-1880.
31. Konstantinidis L., Mameletzi E., Mantel I., Pournaras J.-A., Zografos L., Ambresin A. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch. Clin. Exp. Ophthalmol, 2009, 247, pp. 1165-1171.
32. Konstantinos T., Vasileios E., Somnath B., Theodoros E. Intravitreal aflibercept treatment of retinal angiomatous proliferation: a pilot study and short-term efficacy. Graefes Arch. Clin. Exp. Ophthalmology, 2015, no. 253, pp. 663-665.
33. Kim J.H., Lee T.G., Chang Y.S., Kim S.G, Cho S.W. Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study. Br. J. Ophthalmology, 2016, no. 100, pp. 1634-1639.
34. Matsumoto N., Sato T., Morimoto M., Mukai R. et al. Treat-and-extend Regiment with aflibercept for retinal angiomatous proliferation. Retina, 2016, no. 36, pp. 2282-2289.